Review committee to start work on coronavirus response, says WHO

The Review Committee of the International Health Regulations (IHR) will begin its work on Tuesday to evaluate the functioning of the IHR during the Covid-19 pandemic so far, chief of the WHO said

WHO
World Health Organisation
IANS Geneva
2 min read Last Updated : Sep 08 2020 | 11:46 AM IST

The Review Committee of the International Health Regulations (IHR) will begin its work on Tuesday to evaluate the functioning of the IHR during the Covid-19 pandemic so far, chief of the World Health Organization (WHO) said.

"The International Health Regulations is the most important legal instrument in global health security," Xinhua news agency quoted WHO Director-General Tedros Adhanom Ghebreyesus as saying a virtual press conference on Monday.

"As a reminder, the review committee will evaluate the functioning of the IHR during the pandemic so far, and recommend any changes it believes are necessary.

"It will review the convening of the Emergency Committee, the declaration of a public health emergency of international concern, the role and functioning of national IHR focal points, and will examine progress made in implementing the recommendations of previous International Health Regulations review committees," Tedros added.

Depending on the progress made, he said, the committee may present an interim progress report to the resumed World Health Assembly in November, and a final report to the Assembly in May 2021.

According to the WHO's website, the review committee is expected to hold its first meeting soon.

It will be co-chaired by former New Zealand Prime Minister Helen Clark and former Liberian President Ellen Johnson Sirleaf.

The announcement comes as the number of global coronavirus cases has topped 27.2 million, while the deaths have increased to over 891,000.

As of Tuesday morning, the total number of cases stood at 27,002,224 and the fatalities rose to 882,053, according to the Johns Hopkins University.

--IANS

ksk/

 

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusWorld Health OrganisationCoronavirus Vaccine

First Published: Sep 08 2020 | 11:34 AM IST

Next Story